[go: up one dir, main page]

PE20090962A1 - Nuevas composiciones a base de taxoides - Google Patents

Nuevas composiciones a base de taxoides

Info

Publication number
PE20090962A1
PE20090962A1 PE2008001737A PE2008001737A PE20090962A1 PE 20090962 A1 PE20090962 A1 PE 20090962A1 PE 2008001737 A PE2008001737 A PE 2008001737A PE 2008001737 A PE2008001737 A PE 2008001737A PE 20090962 A1 PE20090962 A1 PE 20090962A1
Authority
PE
Peru
Prior art keywords
taxoids
compositions based
new compositions
emulsion
composition
Prior art date
Application number
PE2008001737A
Other languages
English (en)
Inventor
Patricia Rortais
Carine Gachon
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PE20090962A1 publication Critical patent/PE20090962A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) DERIVADOS DE TAXANOS COMPUESTOS POR UNA EMULSION A BASE DE ACEITES DE SOYA Y TRIGLICERIDOS CON CADENAS MEDIAS, B) LECITINA NATURAL SELECCIONADA DE LECITINA DE SOJA, DE HUEVO O HEMISINTESIS SELECCIONADA ENTRE LAS FOSFATIDILCOLINAS, C) COMO AGENTE TENSIOACTIVO ANIONICO UN FOSFATIDILGLICEROL SELECCIONADO ENTRE DILAUROILFOSFATIDILGLICEROL, DIMIRISTOILFOSFATIDILGLICEROL, DIPALMITOILFOSFATIDILGLICEROL. DICHA COMPOSICION ES INYECTABLE EN FORMA DE EMULSION Y TIENE UN pH ENTRE 3 Y 7 MEDIANTE LA ADICION DE ACIDO CLORHIDRICO, CITRICO, ASCORBICO, SIENDO UTILES EN EL TRATAMIENTO DE LEUCEMIA Y TUMORES
PE2008001737A 2007-10-10 2008-10-07 Nuevas composiciones a base de taxoides PE20090962A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0707092A FR2922107B1 (fr) 2007-10-10 2007-10-10 Nouvelles compositions a base de taxoides

Publications (1)

Publication Number Publication Date
PE20090962A1 true PE20090962A1 (es) 2009-08-10

Family

ID=39356621

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001737A PE20090962A1 (es) 2007-10-10 2008-10-07 Nuevas composiciones a base de taxoides

Country Status (38)

Country Link
US (1) US8481589B2 (es)
EP (1) EP2197492B1 (es)
JP (1) JP5574965B2 (es)
KR (1) KR20100075490A (es)
CN (1) CN101820918A (es)
AR (1) AR072333A1 (es)
AT (1) ATE534406T1 (es)
AU (1) AU2008345527A1 (es)
BR (1) BRPI0818597A2 (es)
CA (1) CA2701789A1 (es)
CL (1) CL2008003002A1 (es)
CO (1) CO6260107A2 (es)
CR (1) CR11335A (es)
CY (1) CY1112388T1 (es)
DK (1) DK2197492T3 (es)
DO (1) DOP2010000098A (es)
EA (1) EA016619B1 (es)
ES (1) ES2377352T3 (es)
FR (1) FR2922107B1 (es)
GT (1) GT201000075A (es)
HR (1) HRP20120165T1 (es)
IL (1) IL204950A0 (es)
MA (1) MA31840B1 (es)
MX (1) MX2010003914A (es)
NI (1) NI201000048A (es)
NZ (1) NZ584544A (es)
PA (1) PA8798101A1 (es)
PE (1) PE20090962A1 (es)
PL (1) PL2197492T3 (es)
PT (1) PT2197492E (es)
RS (1) RS52131B (es)
SI (1) SI2197492T1 (es)
TN (1) TN2010000129A1 (es)
TW (1) TW200922552A (es)
UA (1) UA97418C2 (es)
UY (1) UY31386A1 (es)
WO (1) WO2009083664A1 (es)
ZA (1) ZA201002504B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120065255A1 (en) * 2009-10-19 2012-03-15 Nagesh Palepu Cabazitaxel formulations and methods of preparing thereof
PL2493466T3 (pl) 2009-10-29 2021-11-15 Sanofi Mature Ip Nowe przeciwguzowe zastosowanie kabazytakselu
WO2011139899A2 (en) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JP2012051823A (ja) * 2010-08-31 2012-03-15 Fujifilm Corp 難容性薬物含有水中油型乳化組成物及びその製造方法
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN104225615B (zh) * 2014-09-24 2017-02-01 东南大学 一种紫杉醇类磷脂化合物、其药物组合物及应用
EP3384961B1 (en) * 2017-04-05 2021-10-13 RaySearch Laboratories AB System and method for modelling of dose calculation in radiotherapy treatment planning

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750561A (en) * 1991-07-08 1998-05-12 Rhone-Poulenc Rorer, S.A. Compositions containing taxane derivatives
FR2678833B1 (fr) 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
JP3208517B2 (ja) * 1992-07-01 2001-09-17 ブリストル−マイヤーズ スクイブ カンパニー ７，８−シクロプロパタキサン類
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
FR2698543B1 (fr) 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.
US6537579B1 (en) * 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
US6372780B2 (en) * 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
TR200100575T2 (tr) * 1998-08-20 2001-07-23 Aventis Pharma S.A. Taksoid türevlerinin yeni kullanım alanları
US20020001613A1 (en) * 2000-02-08 2002-01-03 Susan Niemiec Method of manufacturing liposomes
US20030099674A1 (en) * 2001-08-11 2003-05-29 Chen Andrew X. Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
AU2004234003A1 (en) * 2003-04-29 2004-11-11 Baxter International Inc. Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
EP1498120A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid formulations for the oral administration of taxoids
EP1498143A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
JP5089887B2 (ja) * 2006-01-23 2012-12-05 日本精化株式会社 生理活性物質含有複合体

Also Published As

Publication number Publication date
JP5574965B2 (ja) 2014-08-20
MX2010003914A (es) 2010-05-17
FR2922107B1 (fr) 2010-02-26
HRP20120165T1 (hr) 2012-03-31
EA201070448A1 (ru) 2010-08-30
UA97418C2 (ru) 2012-02-10
GT201000075A (es) 2012-04-11
JP2011500542A (ja) 2011-01-06
MA31840B1 (fr) 2010-11-01
PT2197492E (pt) 2012-02-20
CL2008003002A1 (es) 2009-10-16
WO2009083664A8 (fr) 2010-05-14
EP2197492B1 (fr) 2011-11-23
ATE534406T1 (de) 2011-12-15
WO2009083664A1 (fr) 2009-07-09
DOP2010000098A (es) 2010-04-30
CA2701789A1 (fr) 2009-07-09
AR072333A1 (es) 2010-08-25
CR11335A (es) 2010-08-13
PA8798101A1 (es) 2009-07-23
CO6260107A2 (es) 2011-03-22
TN2010000129A1 (fr) 2011-09-26
IL204950A0 (en) 2010-11-30
BRPI0818597A2 (pt) 2015-04-22
NI201000048A (es) 2010-08-20
ZA201002504B (en) 2011-06-29
RS52131B (sr) 2012-08-31
CY1112388T1 (el) 2015-12-09
FR2922107A1 (fr) 2009-04-17
CN101820918A (zh) 2010-09-01
US20100311825A1 (en) 2010-12-09
PL2197492T3 (pl) 2012-05-31
TW200922552A (en) 2009-06-01
EP2197492A1 (fr) 2010-06-23
DK2197492T3 (da) 2012-03-12
NZ584544A (en) 2012-04-27
US8481589B2 (en) 2013-07-09
SI2197492T1 (sl) 2012-03-30
AU2008345527A1 (en) 2009-07-09
ES2377352T3 (es) 2012-03-26
EA016619B1 (ru) 2012-06-29
UY31386A1 (es) 2009-05-29
KR20100075490A (ko) 2010-07-02

Similar Documents

Publication Publication Date Title
PE20090962A1 (es) Nuevas composiciones a base de taxoides
MY145160A (en) A composition and method for making a proppant
ECSP12011884A (es) Proceso para la extracción de petróleo utilizando mezclas de agentes tensioactivos
CL2011001295A1 (es) Compuestos derivados de 1h-pirazol-4-carboxamida; metodo de control o prevencion de una infestacion de plantas utiles por microorganismos fitopatogenos; composicion pesticida que comprende a dichos compuestos.
DE602007005024D1 (de) Verfahren zur herstellung von konzentrierten tensidzusammensetzungen
MX2012006707A (es) Composiciones con patrones y orientaciones visuales.
ECSP099654A (es) Métodos para producir plantas de palma aceitera haploides y doble haploides
CO6761383A2 (es) Aminas grasas, amidoaminas y sus derivados de a metátesis de aceites naturales
WO2007147774A3 (de) Farbstoffmischungen von faserreaktiven azofarbstoffen, ihre herstellung und ihre verwendung
AR090481A1 (es) Uso de un agente alcalino suave en la recuperacion de petroleo
AR078628A1 (es) Proceso para la extraccion de petroleo utilizando mezclas de agentes tensioactivos
CR8360A (es) 1,3 dimetilbutilcarboxanilidas
MX2017015384A (es) Extension de horma de zapato.
AR078629A1 (es) Proceso para la extraccion terciaria de petroleo utilizando mezclas de agentes tensioactivos
MX2009003459A (es) Derivados de 2,3,3-trimetilciclopent-3-encarbaldehido utiles como odorantes.
EA200800148A1 (ru) Применение фуллерена с60 в качестве стабилизатора масел
ATE479688T1 (de) Herstellung von famciclovir und anderen purinderivaten
AR094914A1 (es) Composición tensioactiva codisolvente de fenol-etoxilato
AR064569A1 (es) Legumbres con alto contenido de zinc
BR112017000819A2 (pt) composições e métodos para o tratamento de poços de óleo e gás
MY146622A (en) N-phenylpyrazole derivatives as pesticides
MX390678B (es) Composición edulcorante y métodos para su fabricación
AR059452A1 (es) Un solvente no ionico , una composicion farmaceutica estabilizada que comprende un taxano y un proceso para la preparacion del solvente no ionico
BRPI0519812A2 (pt) método para a obtenção de células de algas castanhas liofilizadas
CO2024006327A2 (es) Método para el tratamiento de una enfermedad de esclerodermia

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed